GW&K Investment Management’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $129M | Sell |
1,494,723
-21,622
| -1% | -$1.94M | 1.14% | 7 |
|
|
2025
Q4 | $132M | Sell |
1,516,345
-261,086
| -15% | -$19.8M | 1.14% | 7 |
|
|
2025
Q3 | $102M | Sell |
1,777,431
-72,271
| -4% | -$4.16M | 0.9% | 17 |
|
|
2025
Q2 | $109M | Buy |
1,849,702
+129,774
| +8% | +$8.38M | 0.98% | 13 |
|
|
2025
Q1 | $126M | Sell |
1,719,928
-25,187
| -1% | -$2.08M | 1.17% | 4 |
|
|
2024
Q4 | $144M | Sell |
1,745,115
-7,457
| -0.4% | -$588K | 1.23% | 4 |
|
|
2024
Q3 | $125M | Sell |
1,752,572
-7,322
| -0.4% | -$517K | 1.07% | 7 |
|
|
2024
Q2 | $121M | Buy |
1,759,894
+13,241
| +0.8% | +$791K | 1.1% | 6 |
|
|
2024
Q1 | $93.7M | Sell |
1,746,653
-13,330
| -0.8% | -$717K | 0.83% | 17 |
|
|
2023
Q4 | $93.8M | Buy |
1,759,983
+96,713
| +6% | +$4.71M | 0.87% | 13 |
|
|
2023
Q3 | $82.6M | Sell |
1,663,270
-25,852
| -2% | -$1.45M | 0.83% | 19 |
|
|
2023
Q2 | $101M | Sell |
1,689,122
-10,973
| -0.6% | -$625K | 0.95% | 12 |
|
|
2023
Q1 | $96.3M | Sell |
1,700,095
-12,056
| -0.7% | -$773K | 0.93% | 10 |
|
|
2022
Q4 | $127M | Buy |
1,712,151
+135,935
| +9% | +$9.26M | 1.29% | 4 |
|
|
2022
Q3 | $93.9M | Buy |
1,576,216
+52,041
| +3% | +$3.13M | 1.04% | 10 |
|
|
2022
Q2 | $85.6M | Sell |
1,524,175
-10,230
| -0.7% | -$672K | 0.92% | 16 |
|
|
2022
Q1 | $113M | Buy |
1,534,405
+21,525
| +1% | +$1.5M | 1.01% | 12 |
|
|
2021
Q4 | $109M | Buy |
1,512,880
+24,130
| +2% | +$1.75M | 0.91% | 13 |
|
|
2021
Q3 | $114M | Sell |
1,488,750
-13,039
| -0.9% | -$1.05M | 1.02% | 8 |
|
|
2021
Q2 | $116M | Buy |
1,501,789
+12,327
| +0.8% | +$876K | 1.01% | 10 |
|
|
2021
Q1 | $91.9M | Buy |
1,489,462
+69,098
| +5% | +$4.38M | 0.85% | 19 |
|
|
2020
Q4 | $92.6M | Buy |
1,420,364
+63,285
| +5% | +$3.64M | 0.97% | 10 |
|
|
2020
Q3 | $67.2M | Buy |
1,357,079
+373,501
| +38% | +$19.3M | 0.88% | 12 |
|
|
2020
Q2 | $46.9M | Sell |
983,578
-95,333
| -9% | -$4.6M | 0.66% | 35 |
|
|
2020
Q1 | $45.9M | Sell |
1,078,911
-327,740
| -23% | -$16.2M | 0.81% | 25 |
|
|
2019
Q4 | $82.8M | Sell |
1,406,651
-40,483
| -3% | -$2.2M | 1.11% | 8 |
|
|
2019
Q3 | $74M | Buy |
1,447,134
+378,211
| +35% | +$18M | 1.04% | 10 |
|
|
2019
Q2 | $45.2M | Sell |
1,068,923
-21,776
| -2% | -$946K | 0.69% | 29 |
|
|
2019
Q1 | $53.9M | Sell |
1,090,699
-51,335
| -4% | -$2.32M | 0.87% | 20 |
|
|
2018
Q4 | $49.4M | Sell |
1,142,034
-47,918
| -4% | -$2.39M | 0.98% | 15 |
|
|
2018
Q3 | $67.5M | Sell |
1,189,952
-6,377
| -0.5% | -$336K | 1.09% | 11 |
|
|
2018
Q2 | $60.4M | Sell |
1,196,329
-8,180
| -0.7% | -$427K | 0.99% | 16 |
|
|
2018
Q1 | $60M | Sell |
1,204,509
-85,525
| -7% | -$4.02M | 1.01% | 13 |
|
|
2017
Q4 | $53M | Sell |
1,290,034
-148,394
| -10% | -$5.2M | 0.91% | 22 |
|
|
2017
Q3 | $42.8M | Sell |
1,438,428
-4,794
| -0.3% | -$146K | 0.71% | 43 |
|
|
2017
Q2 | $47.8M | Sell |
1,443,222
-44,531
| -3% | -$1.4M | 0.83% | 31 |
|
|
2017
Q1 | $44.1M | Sell |
1,487,753
-3,743
| -0.3% | -$102K | 0.83% | 30 |
|
|
2016
Q4 | $37M | Sell |
1,491,496
-229,053
| -13% | -$5.21M | 0.72% | 44 |
|
|
2016
Q3 | $38.8M | Sell |
1,720,549
-21,202
| -1% | -$498K | 0.73% | 43 |
|
|
2016
Q2 | $41.5M | Buy |
1,741,751
+154,696
| +10% | +$3.71M | 0.86% | 25 |
|
|
2016
Q1 | $37.7M | Buy |
1,587,055
+51,358
| +3% | +$1.26M | 0.84% | 33 |
|
|
2015
Q4 | $42.7M | Sell |
1,535,697
-42,052
| -3% | -$1.06M | 1% | 20 |
|
|
2015
Q3 | $32.6M | Buy |
1,577,749
+28,689
| +2% | +$727K | 0.78% | 40 |
|
|
2015
Q2 | $39.8M | Sell |
1,549,060
-39,889
| -3% | -$1.01M | 0.9% | 35 |
|
|
2015
Q1 | $40.1M | Sell |
1,588,949
-23,239
| -1% | -$566K | 0.91% | 35 |
|
|
2014
Q4 | $38.3M | Buy |
1,612,188
+6,067
| +0.4% | +$134K | 0.92% | 38 |
|
|
2014
Q3 | $31.6M | Buy |
1,606,121
+309,444
| +24% | +$6.37M | 0.83% | 44 |
|
|
2014
Q2 | $31M | Buy |
1,296,677
+497,087
| +62% | +$12M | 0.79% | 50 |
|
|
2014
Q1 | $21.3M | Buy |
+799,590
| New | +$19M | 0.57% | 76 |
|
Other funds holding GMED
VCM
VPM
SC
GW&K Investment Management's GMED Position: Q1 2026 in Review
GW&K Investment Management reduced its Globus Medical (GMED) stake by 1.4% in Q1 2026, selling an estimated $1.94M and leaving 1,494,723 shares worth $129M. The position accounts for 1.14% of the portfolio, ranked #7.
GW&K Investment Management first reported a position in GMED in Q1 2014 and has held it in 49 quarters since. The position peaked at $144M in Q4 2024. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.
- GW&K Investment Management held 1,494,723 shares of Globus Medical worth $129M as of Q1 2026.
- GW&K Investment Management sold 21,622 Globus Medical shares in Q1 2026, an estimated $1.94M.
- Globus Medical made up 1.14% of GW&K Investment Management's portfolio in Q1 2026, its #7 holding.
- GW&K Investment Management first reported a position in Globus Medical in Q1 2014 and has held it in 49 quarters since.
- GW&K Investment Management's Globus Medical position peaked at $144M in Q4 2024.
- 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.
Based on GW&K Investment Management's 13F filing for Q1 2026, filed 13 May 2026.